baber/WOPTO huggingface dataset:
Patent CA-3092115-A1 (CA)
Inventor: MARKOVSKI BOBBY
IPC: E04F15/02
Filed: 2019-01-28
Abstract: The invention relates to a Joining system for floor panels (10, 20), comprising a female coupling recess (30) formed in a first floor panel (10), said female coupling recess (30) being adapted to receive a male coupling tongue (40) projecting from an adjoining second floor panel (20) in a direction perpendicular to a main floor surface plane (SP) in which the floor panels (10, 20) are laid. The joining system further includes an elasticity slot (70) for facilitating resilient movement in said vertical snap joint interlocking engagement.
Patent CA-3096012-A1 (CA)
Title: Aiguille creuse et systeme de moyeu pivotant
Inventor: WEKSEL DAVID
IPC: A61M5/42
Filed: 2018-06-19
Abstract: La présente invention concerne un système d'aiguilletage, destiné à être utilisé dans des domaines médicaux et d'autres domaines dans lesquels de fines aiguilles creuses sont utilisées pour injecter ou aspirer des fluides et des gaz. Le système d'aiguilletage comprend une aiguille à corps tubulaire rigide mince qui est ouverte aux deux extrémités et sur toute la longueur, et ayant une extrémité pointue. Le corps d'aiguille et le moyeu sont conçus et peuvent être fabriqués de sorte que l'aiguille a une extrémité sphérique qui s'insère dans une douille du moyeu formant un joint et permettant à l'aiguille d'être orientée de sorte que l'axe central d'aiguille est non colinéaire et non parallèle avec l'axe central du moyeu. En fonction de l'utilisation souhaitée, l'orientation de l'aiguille par rapport au moyeu peut être limitée d'un volume conique à une orientation angulaire plane ou à plans multiples. L'aiguille ainsi conçue permet avantageusement à l'utilisateur de contourner un obstacle et/ou des obstacles qui empêchent par ailleurs un accès linéaire direct à un point d'intérêt, au moyen d'un dispositif qui peut aller autour ou entre des obstructions fournissant un trajet direct optimal vers le point d'administration de thérapie souhaité.
Patent CA-3097393-A1 (CA)
Inventor: WATSON JAMES
IPC: G06N3/08
Filed: 2020-05-02
Abstract: A method for training a depth estimation model with depth hints is disclosed.  For each image pair: for a first image, a depth prediction is determined by the depth estimation model and a depth hint is obtained; the second image is projected onto the first image once to generate a synthetic frame based on the depth prediction and again to generate a hinted synthetic frame based on the depth hint; a primary loss is calculated with the synthetic frame;  a hinted loss is calculated with the hinted synthetic frame; and an overall loss is calculated for the image pair based on a per-pixel determination, wherein if the hinted loss is smaller than the primary loss, then the overall loss includes the primary loss and a supervised depth loss between depth prediction and depth hint. The depth estimation model is trained by minimizing the overall losses for the image pairs.
Patent CA-3098345-A1 (CA)
Inventor: CURRY DAVID D
IPC: E05D7/00
Filed: 2020-11-06
Abstract: Abrégé : Il est décrit une charnière de porte ajustable qui comprend un support, ainsi quun ensemble de pignon dengrenage qui est adapté pour ajuster lalignement de charnière par rapport à lencadrement ou au châssis de porte. Pendant que le pignon dengrenage tourne, un ensemble de supports dengrenage sert densemble de coins isocèles qui changent lalignement de la charnière par rapport à lencadrement ou au châssis de porte. Une fois lalignement de la charnière souhaité atteint, des vis de montage de charnière peuvent être serrées afin dattacher lassemblage, de manière amovible, dans lalignement ou lemplacement approprié. Date reçue/Date Received 2020-11-06
Patent CA-3098922-A1 (CA)
Inventor: ZHANG WANQIN
IPC: C07K7/08
Filed: 2018-11-15
Abstract: The present disclosure disclosed a synthetic peptide sp2 and an application thereof; the sp2 comprises the amino acid sequence shown in SEQ ID No. 1. 5p2 has obvious anti-tumor growth activity on xenograft tumours such as subcutaneous human pancreatic cancer, human cervical cancer, and human ovarian cancer in nude mice, with a dose-effect and time-effect relation; and has the effect of delaying metastasis and prolonging the survival time of nude mouse having in situ transplantation of human pancreatic cancer and lung adenocarcinoma. After the animals were given intravenous injection of sp2 at a dose of 2000 mg/kgBW, no toxicity reaction and death were observed. The applications of sp2 also include: (1) preventing and/or treating of tumor; (2) inhibiting proliferation and/or growth and/or invasion of tumor cells; (3) enhancing the anti-tumor immune response; (4) inducing tumor cell differentiation; (5) preparing anti-tumor drugs; (6) inhibiting tumor telomerase activity; (7) regulating the tumor cell cycle.
Patent CA-3102531-A1 (CA)
Inventor: SIMPSON DAVID M
IPC: C07D233/60
Filed: 2014-01-31
Abstract: ABSTRACT Certain amine compounds and their use against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The clairned compounds are quinolin-4-amine compounds and their pharmaceutically acceptable salts, represented by the formula; (CH2)õ(0)p(CH2)q I-IN R5 IA 1 a I R4 Ri- -R2 wherein n is 2, 3, 4, 5, 6, 7, or 8; p is 1; q is 0; R1 is hydrogen and R2 is hydrogen; R4 is hydrogen; and R5 is alkoxy having from 1 to 6 carbon atoms unsubstituted or substituted by phenyl; or wherein n is 0; p is 0; q is 1; R1 is hydrogen and R2 is hydrogen; R4 is hydrogen or halo; and R5 is alkoxy having 6 or 10 carbon atoms, phenoxy, or alkoxy having from 1 to 10 carbon atoms substituted by phenyl.
Patent CA-3103609-A1 (CA)
Title: Robinet integre et seche-linge a flux de recirculation
Inventor: GALLOB RANDALL
IPC: A47K1/04
Filed: 2019-06-11
Abstract: Un mode de réalisation de l'invention concerne un système d'évier ayant un mécanisme de recirculation d'air pour l'air de sèche-mains évacué. Le système d'évier comprend un plateau d'évier ayant une ouverture d'évier et une coque extérieure. Le plateau d'évier est séparé d'une région de lavabo d'évier d'un lavabo d'évier par un anneau d'évent. Un lavabo d'évier définit une région de lavabo d'évier et une région de plénum. La région de plénum est séparée de la région de lavabo d'évier par l'anneau d'évent. Une cavité de plénum est formée entre une surface interne de la coque extérieure et la région de plénum. L'anneau d'évent comprend un évent avec une ouverture associée. L'ouverture est exposée à la région de lavabo d'évier et à une zone située sous le plateau d'évier, l'ouverture permettant un écoulement d'air à travers celle-ci. Un séchoir est conçu pour diriger de l'air forcé à travers un orifice d'échappement de séchoir dans la région de lavabo d'évier du lavabo d'évier.
Patent CA-3103802-A1 (CA)
Inventor: JUNG ANA
IPC: H05B33/22
Filed: 2019-06-12
Abstract: A device for converting solar radiation is described wherein the device comprises an inorganic luminescent material comprising a host material doped with Mn5+ ions for converting radiation of the UV and/or visible part of the electromagnetic spectrum into radiation of the near-infrared radiation part of the electromagnetic spectrum, preferably the infrared part between 1150 nm and 1250 nm, preferably around 1190 nm (the infrared emission peak of Mn5+); or, an amorphous host material doped with Sm2+ or Tm2+ ions, the amorphous host material including the elements Al, Si, O and N (SiAION) for converting radiation of the UV and/or visible part of the electromagnetic spectrum into radiation of a longer wavelength, preferably a longer wavelength between 650 nm and 800 nm or a longer wavelength of around 1140 nm; and, at least one photovoltaic device for converting at least part of the converted radiation into electrical power.
Patent CA-3104634-A1 (CA)
Inventor: KAIR LEE
IPC: G06K9/66
Filed: 2019-06-19
Abstract: In a transportation security technique, images are stored that are received from image capturing equipment deployed at respective screening nodes. The images are analyzed using a machine learning model, where presence of a particular object in an image indicates that a threat condition exists at the screening node. The analyzed images are transmitted to threat assessment components in accordance with predetermined criteria. An indication that the particular object is observed in the image is received from the threat assessment components. An indication that the particular object is observed in the image is transmitted to the screening node responsive to receiving the indication that the particular object is observed in the image. An indication of whether the particular object is present at the screening node is received. The machine learning model is trained based on the received indication of whether the particular object is observed in the image.
Patent CA-3107174-A1 (CA)
Inventor: STROYER ANKE
IPC: A61K9/20
Filed: 2019-07-19
Abstract: The invention relates to pharmaceutical dosage forms, which can be administered orally and have a modified release and contain (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclopropylpropanoic acid, and to processes for preparing the dosage forms and to the use thereof for treating and/or preventing diseases, in particular for treating and/or preventing cardiac, renal, pulmonary and ophthalmological disorders, disorders of the central nervous system, fibrotic and inflammatory disorders and metabolic diseases.
Patent CA-3107996-A1 (CA)
Inventor: POMEDLI ALEX ISTVAN
IPC: B02C23/18
Filed: 2021-02-02
Abstract: Described are various embodiments of a continuous sluicing method, and system using same.
Patent CA-3110444-A1 (CA)
Inventor: CLARKE NIGEL
IPC: G01N33/49
Filed: 2019-08-21
Abstract: The present disclosure relates to methods of detecting various analytes, including glycated hemoglobin (HbA1c) and total hemoglobin (THb), in a biological sample obtained with a microsampling device.
Patent CA-3111724-A1 (CA)
Title: Ventilator and airbag for a ventilator
Inventor: KIM WOO SOO
IPC: A61M16/08
Filed: 2021-03-10
Abstract: There is described a ventilator for providing breathable air to a patient. The ventilator includes an airbag defining a longitudinal axis, having a first end, a second end, and a foldable wall extending from the first end to the second end, and being movable from a decompressed state to a compressed state by moving the first end along the longitudinal axis relative to the second end. The wall has fold lines formed therein such that, during movement of the airbag from the decompressed state to the compressed state, the wall is folded along the fold lines. The fold lines define at least one polygonal surface portion of the wall. The ventilator further includes an actuator for driving compression and decompression of the airbag, and a controller for controlling the actuator.
Patent CA-3113399-A1 (CA)
Inventor: DURIG THOMAS
IPC: A61K47/32
Filed: 2019-09-17
Abstract: A peroxide stable polymer composition comprises a mixture of polyvinylpyrrolidone/vinyl acetate copolymer (PVP/VA) and butylated hydroxy anisole (BHA), an antioxidant. Products or applications comprising said stable polymer composition and a process for the preparation thereof are disclosed in the present application.
Patent CA-3113885-A1 (CA)
Inventor: KEMPARAJU GAUTHAM RAJ
IPC: F21V21/14
Filed: 2021-03-31
Abstract: Un appareil d'éclairage comprend un logement supérieur et un logement inférieur. Un mécanisme de rotation-inclinaison est interposé entre les deux logements pour permettre au logement inférieur dêtre tourné et incliné par rapport au logement supérieur.
Patent CA-3114287-A1 (CA)
Inventor: SCOTT DAVID
IPC: F17D3/12
Filed: 2021-04-07
Abstract: Systems and methods of injecting hydrate inhibiting chemicals into a gaseous fuel line of a burner are described. One system includes: an oilfield burner; a gaseous fuel line connected to the oilfield burner; a storage tank containing hydrate-inhibiting chemicals; a hydrate-inhibiting chemical supply line connected between the storage tank and the gaseous fuel line;  and a control valve connected to control flow in the hydrate-inhibiting chemical supply line in response to the operation of the oilfield burner. A kit may be provided with at least the hydrate-inhibiting chemical supply line and control valve.
Patent CA-3115777-A1 (CA)
Title: Selectively permeable floor mat
Inventor: BING RICHARD
IPC: A47G27/02
Filed: 2019-10-10
Abstract: A permeable mat (10) provides a two-state mat; one in which the mat (10) has an impervious layer (12) when laid flat during use, so water gets captured by an upper fabric layer (14). And a second state in which the mat (10) becomes permeable when it is rolled and tumbled in the washer and drier, to allow the through-flow of air and water to effectively clean and dry the mat (10). A pattern of permeable elements (22) may be included as part of the rubber backing (12) to improve washing and drying by allowing easier passage through the mat (10) by water and washing chemicals, allowing water drainage through the rubber layer (12) during spinning cycle, reducing the need for very high spinning forces and speeds, allowing for air flow through the mat layers (12, 14), improving drying time and efficiencies and lowering the structure of the mat unit, thereby allowing for better unrolling and tumbling during washing cycles.
Patent CA-3116324-A1 (CA)
Inventor: SCHIFF CHRISTINA
IPC: G01N33/574
Filed: 2019-10-17
Abstract: The present invention provides diagnostic methods, therapeutic methods, and compositions for the treatment of cancer (e.g., kidney cancer (e.g., renal cell carcinoma (RCC)). The invention is based, at least in part, on the discovery that expression levels of one or more biomarkers described herein in a sample from an individual having cancer can be used in methods of predicting the therapeutic efficacy of treatment with a VEGF antagonist (e.g., an anti-VEGF antibody, (e.g., bevacizumab) or a VEGFR inhibitor (e.g., a multi-targeted tyrosine kinase inhibitor (e.g., sunitinib, axitinib, pazopanib, or cabozantinib))) and a PD-L1 axis binding antagonist (e.g., a PD-L1 binding antagonist (e.g., anti-PD-L1 antibody, e.g., atezolizumab (MPDL3280A)) or a PD-1 binding antagonist (e.g., anti-PD-1 antibody)), or with an angiogenesis inhibitor (e.g., a VEGF antagonist (e.g., a VEGFR inhibitor, (e.g., a multi-targeted tyrosine kinase inhibitor (e.g., sunitinib, axitinib, pazopanib, or cabozantinib)))).
Patent CA-3117298-A1 (CA)
Title: Learning user actions to improve transaction categorization
Inventor: LIU JUAN
IPC: G06Q40/02
Filed: 2021-05-06
Abstract: A method may include executing a baseline classifier on unreviewed transaction features of an unreviewed transaction record to obtain a baseline account identifier, and executing a comparison model on (i) an unreviewed transaction vector of the unreviewed transaction record and (ii) reviewed transaction vectors to obtain comparison scores. The reviewed transaction vectors may correspond to reviewed transaction records each having a user-approved account identifier. The method may further include selecting, using the comparison scores, a reviewed transaction record. The reviewed transaction record may correspond to a comparison score. The comparison score may correspond to a user- approved account identifier of the reviewed transaction record. The method may further include selecting, using the comparison score, one of the baseline account identifier and the user-approved account identifier to obtain a selected account identifier, and presenting the selected account identifier for the unreviewed transaction record.
Patent CA-3120055-A1 (CA)
Inventor: PARK JI-YEON
IPC: A61K31/4439
Filed: 2019-11-14
Abstract: A compound of formula (1), stereoisomers or pharmaceutically acceptable salts thereof: wherein Ri and R2 are H, Ci-6-alkyl, Ci-6-alkoxy, Ci-6-hydroxyalkyl, Ci-6-cyanoalkyl, C1-6- haloalkyl, hydroxy, cyano, halogen, C(=O)-OH, C(=O)-O-Ci-6-alkyl, S(=O)2-Ci-6-alkyl, aryl or heteroaryl; X-Y-Z is C=CA2-NAs, N-CA2=CA3 or C=N-NA5; A2, A3 and As are H, Ci-6-alkyl, Ci-6-alkoxy, Ci-6-hydroxyalkyl, Ci-6-haloalkyl, Ci-6-cyanoalkyl, C(=O)-OH, C(=O)-O-Ci-6-alkyl, S(=O)2-Ci-6-alkyl, -C(=O)-NH-Ci-6-haloalkyl, aryl or heteroaryl; n and m = 0 to 3; Bi is -C(=O)-, -C(=S)-, -C(=0)-NR3- or a single bond; B2 is C3-7- cycloalkyl, 5-6-membered heterocycloalkyl, aryl or heteroaryl; B3 is H or Ci-6-alkyl; Di is -NR3-; D2 is -C(=O)-, -C(=S)-, -S(=O)2- or a single bond; D3 is -NR3-, or a single bond; D4 is H, Ci-6-alkyl, Ci-6-alkenyl, Ci-6-haloalkyl, C1-6- cyanoalkyl, Cs-7-cycloalkyl, 5-6-membered heterocycloalkyl, Ci-6-alkyl substituted with a methylpiperazinyl, aryl or heteroaryl; and R3 and R4 are H, Ci-6-alkyl or Ci-6-haloalkyl. Pharmaceutical compositions comprising said compounds, stereoisomers or salts, and medical uses of said compounds, stereoisomers or salts.
Patent CA-3120687-A1 (CA)
Title: Oligonucleotides for reduction of pd-l1 expression
Inventor: PEDERSEN LYKKE
IPC: C12N15/113
Filed: 2017-03-14
Abstract: The present invention relates to antisense oligonucleotides that are capable of reducing expression of PD-L1 in a target cell. The oligonucleotides hybridize to PD-L1 mRNA. The present invention further relates to conjugates of the oligonucleotide and pharmaceutical compositions and methods for treatment of viral liver infections such as HBV, HCV and HDV;  parasite infections such as malaria, toxoplasmosis, leishmaniasis and trypanosomiasis or liver cancer or metastases in the liver using the oligonucleotide.
Patent CA-3120732-A1 (CA)
Title: Operation control system, operation control method and device and medium
Inventor: LIU PENG
IPC: G06F17/00
Filed: 2018-11-21
Abstract: A job control system, a job control method, an apparatus, a device, and a medium, comprising: a control terminal (10) and a job drone (20), wherein: the control terminal (10) is configured to obtain map tile data corresponding to a job region, to generate a region map of the job region according to the map tile data for display, to determine, according to at least one region positioning point selected by a user for the region map, at least one job site in the job region, to generate a job route corresponding to the job site, and to send it to the job drone (20); the job drone (20) is configured to receive the job route, and to perform a flight job in at least one job site according to the job route.
Patent CA-3121907-A1 (CA)
Title: Method for treating an alcohol feedstock for the production of olefins
Inventor: ARIBERT NICOLAS
IPC: C07C29/76
Filed: 2019-11-27
Abstract: The invention concerns a method for treating an alcohol feedstock comprising: a) a step of preheating the alcohol feedstock to a temperature of between 70°C and 200°C; b) a step of pretreatment on an acidic solid, carried out at a temperature of between 70°C and 200°C, in order to produce a pretreated alcohol feedstock; c) a step of partial vaporisation in order to produce a vaporised stream and a liquid stream; and d) a step of purifying the liquid stream from step c), into a stream rich in water, a stream rich in mono-alcohol and a stream rich in impurities.
Patent CA-3122047-A1 (CA)
Inventor: BEN TRAD ABDERRAZEK
IPC: E06B3/66
Filed: 2020-03-05
Abstract: La présente invention concerne une unité de vitrage isolant sous vide (10) s'étendant le long d'un plan, P, délimité par un axe longitudinal, X, et un axe vertical, Z, pourvu d'un revêtement réfléchissant les infrarouges, ayant une longueur L avec 300 mm = L = 4 000 mm, et une largeur W, avec 300 mm = W = 1 500 mm, et comprenant : a. une première vitre (1) ayant une face interne (12) de vitre et une face externe (13) de vitre, ayant une épaisseur Z1, la première vitre revêtue présentant une absorptance d'énergie EA1 et b. une seconde vitre (2) ayant une face interne (22) de vitre et une face externe (23) de vitre et ayant une épaisseur, Z2, et supportant le revêtement réfléchissant les infrarouges sur sa face interne de vitre, les épaisseurs étant mesurées selon la direction perpendiculaire au plan, P, la seconde vitre présentant une absorptance d'énergie EA2 ; c. un ensemble d'éléments d'espacement individuels (3) positionné entre les première et seconde vitres, maintenant une distance entre les première et seconde vitres et formant un réseau ayant un pas ?, le pas ? étant compris entre 10 mm et 35 mm ; d. un joint d'étanchéité à liaison hermétique (4) scellant la distance entre les première et seconde vitres sur un périmètre de celles-ci ; e. un volume interne, V, délimité par les première et seconde vitres et l'ensemble d'éléments d'espacement individuels et fermé par le joint d'étanchéité à liaison hermétique et dans lequel il existe un vide de pression absolue inférieure à 0,1 mbar, et f. les faces internes de vitre des première et seconde vitres faisant face au volume interne, V ; g. caractérisée en ce que la première vitre est plus épaisse que la seconde vitre (Z1 > Z2), et en ce que ?EA = 0,0033 ?Z /mm - 0,0468 ?Z/mm + 0,7702 ; dans laquelle ?EA = EA1 2*EA2, et en ce que Z1 = 5 mm, Z2 = 3 mm, et ?Z = Z1 - Z2 = 1 mm, et en ce que 10 mm = ? = 35 mm.
Patent CA-3122410-A1 (CA)
Title: Cyclopentyl nucleoside analogs as anti-virals
Inventor: ZHONG MINGHONG
IPC: C07D487/04
Filed: 2019-12-04
Abstract: Described herein are cyclopentyl nucleoside analogs of Formula (I), pharmaceutical compositions that include one or more cyclopentyl nucleoside analogs and methods of using the same to treat HBV, HDV and/or HIV. (I)
Patent CA-3122769-A1 (CA)
Title: Procede et appareil de restrictions de niveau de bloc dependant du mode et de la taille
Inventor: FILIPPOV ALEXEY KONSTANTINOVICH
IPC: H04N19/50
Filed: 2019-12-23
Abstract: L'invention concerne un procédé de prédiction intra d'un bloc d'une image, comprenant, pour un échantillon provenant d'une pluralité d'échantillons du bloc, la détermination d'une valeur d'échantillon prédite à partir d'une ou de plusieurs valeurs d'échantillon de référence par prédiction intra à l'aide d'un mode de prédiction intra sélectionné parmi un mode DC, un mode planaire, et un mode angulaire de prédiction intra ; la détermination d'un premier poids sur la base du mode de prédiction intra et de l'une de la hauteur, de la largeur du bloc, ou des deux ; la détermination d'un second poids similaire au premier poids ; le calcul d'une valeur supplémentaire en tant que somme pondérée d'une valeur d'échantillon de référence supérieure et d'une valeur d'échantillon de référence gauche par pondération desdites valeurs ; la multiplication de la valeur d'échantillon prédite par un facteur de pondération d'échantillon, ce qui permet d'obtenir une valeur d'échantillon prédite pondérée ; l'ajout de la valeur supplémentaire à la valeur d'échantillon prédite pondérée, ce qui permet d'obtenir une valeur d'échantillon prédite modifiée non normalisée ; et la normalisation de la valeur d'échantillon prédite modifiée non normalisée par un décalage à droite arithmétique d'une représentation entière de la valeur d'échantillon prédite modifiée non normalisée, ce qui permet d'obtenir une valeur d'échantillon prédite modifiée normalisée.
Patent CA-3123316-A1 (CA)
Title: Polypeptide with xylanase activity, nucleotide sequence encoding it, ingredient and process comprising said ingredient for preparing a food product
Inventor: CHAVEZ ROSALES RENATO ANTONIO
IPC: A21D8/04
Filed: 2019-12-11
Abstract: The present invention relates to a new polypeptide with xylanase activity, the nucleotide sequence encoding it, an ingredient containing said polypeptide and a process for preparing a food product which comprises adding said ingredient to the preparation. This new polypeptide with xylanase activity is particularly useful for the baking industry, endowing doughs with greater elasticity, less tenacity, formation of a stronger gluten network with less water, shorter mixing time and greater volume of the final product.